Singular Genomics Systems (NASDAQ:OMIC) Price Target Cut to

Singular Genomics Systems (NASDAQ:OMIC – Get Free Report) had its price target dropped by equities research analysts at The Goldman Sachs Group from $0.95 to $0.85 in a note issued to investors on Monday, Benzinga reports. The firm currently has a “neutral” rating on the stock. The Goldman Sachs Group’s price objective suggests a potential […]

Related Keywords

Elin Glezer , , Balyasny Asset Management , Proshare Advisors , Millennium Management , Singular Genomics Systems Inc , Singular Genomics Systems Company Profile , Goldman Sachs Group , Capital Management , Singular Genomics Systems , Get Free Report , Genomics Systems Stock Down , Genomics Systems , Singular Genomics , Asset Management , Share Advisors , Singular Genomics Systems Daily , Nasdaq Omic , Comic , Medical , Lower Price Target , The Goldman Sachs Group Inc ,